Sunday, May 21, 2017 6:06:05 PM
Most are obviously selling every chance they can get. Especially when the volume allows. This is reflected in the lack of buyers and the frailing pps. I would never buy at this level. I would not even consider buying until the risk level is diminished to around $0.005. And even then, it would still only be a consideration.
Heavy Dilution through Equity Financing is inevitable here. There is no way out of that. They need it in order to overcome the weak start-up in their Smart Medical Alliance Venture, and MSO Contracts. Because the script growth has topped-out and now showing contraction. It would be smart to just hold off from being inappropriately influenced to buy now. The pps would then take care of itself, by grinding down into the $0.005 area with no problem at all. This would then eliminate "most" downside risk.
And they are not going to Up-Grade soon. That will take much longer, especially after breaking down below 0.01 again. Then, after the Dilutive Equity Finance Package is complete, they can start building towards a small OTC Up-Grade. But this will take another year or so, no doubt. By then, the pps may climb back to $0.02. Then after the Reverse-Split is complete, I would then wait until the pps settles down again before re-evaluating.
JMO
Recent RXMD News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 03:51:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/06/2024 08:54:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 07:54:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 04:38:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 04:16:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:40:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:34:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:20:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:04:51 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM